Showing results (1-10 of 286) with videos related to
Sort By:
Pageof 29
Cancers|September 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena, et al.Best Practice & Research. Clinical Gastroenterology|September 28, 2014
Chemoembolization and radioembolizationBruno SangroGastroenterologia Y Hepatologia|August 5, 2014
[Survival benefit with intraarterial techniques in hepatocellular carcinoma]Bruno SangroJournal of Hepatology|September 17, 2022
Loss of liver function in chronic liver disease: An identity crisisCarmen Berasain, Maria Arechederra, Josepmaria Argemí, et al.Journal for Immunotherapy of Cancer|October 21, 2025
Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinomaShay Behrens, Whitney Leet Do, Limin Wang, et al.Current Opinion in Molecular Therapeutics|October 2, 2010
Gene therapy for liver cancer: clinical experience and future prospectsBruno Sangro, Jesus PrietoGastroenterologia Y Hepatologia|October 24, 2007
[Diagnosis of small hepatocellular carcinoma]Mercedes Iñarrairaegui, Bruno SangroSeminars in Liver Disease|November 5, 2014
Transarterial chemoembolization and radioembolizationBruno Sangro, Riad SalemCurrent Oncology Reports|February 4, 2014
Nonsurgical treatment for localized hepatocellular carcinomaAndrew S Kennedy, Bruno SangroJournal of Hepatology|September 20, 2017
Targets for immunotherapy of liver cancerTim F Greten, Bruno SangroPageof 29